Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in PBYI — Puma Biotechnology, Inc.

CIK 1115418 BOSTON, MA
Back to PBYI Full portfolio

Position in PBYI

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$466,406
+$127,506 QoQ
Shares Held
57,510
+8.4% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 160 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 19% Shared 0% None 81%

Common Shares in PBYI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. PBYI ranks #188 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in PBYI

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $466,406 57,510
2026-03-31 $338,900 53,036
2025-12-31 $320,675 53,895
2025-09-30 $318,605 60,001
2025-06-30 $207,895 60,611
2025-03-31 $113,353 38,295
2024-12-31 $116,787 38,291
2024-09-30 $118,901 46,628
2024-06-30 $163,880 50,270
2024-03-31 $11,055 2,086
2023-12-31 $9,032 2,086
2023-09-30 $5,486 2,086
2023-06-30 $7,363 2,086
2022-03-31 $111,672 38,775
2021-12-31 $117,863 38,771
2021-09-30 $277,659 39,609
2021-06-30 $358,396 39,041
2021-03-31 $403,273 41,489
2020-12-31 $464,459 45,269
2020-09-30 $423,870 42,009
2020-06-30 $511,810 49,071
2020-03-31 $352,547 41,771